COVID-19 vaccination linked to reduced infections in children with eczema: Study Dr. Kamal Kant Kohli4 Dec 2025 7:00 AM ISTChildren with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if they receive the...
Psoriasis linked to Risk of Diabetic Retinopathy in Type-2 Diabetes Mellitus Patients: Study Dr. Shravani Dali3 Dec 2025 10:15 AM ISTResearchers have found in a new study published in Diabetes Research and Clinical Practice that prior psoriasis in patients with type 2 diabetes...
Broccoli Stem Extract Cream Shows Promise for Post-Acne Pigmentation: Study Medha Baranwal2 Dec 2025 8:30 AM ISTIndonesia: Researchers have found in a new study that a 6% broccoli stem extract cream significantly improved pigmentation in post-acne macular scars,...
Long-term Nemolizumab Improves Atopic Dermatitis in Adolescents: Study Dr. Shravani Dali30 Nov 2025 8:45 PM ISTResearchers have found in a new research that Nemolizumab (30 mg every 4 weeks) combined with topical corticosteroids and/or calcineurin inhibitors...
Physical Intimacy and Oxytocin Aid Stress Reduction and Enhance Wound Healing: JAMA Medha Baranwal28 Nov 2025 8:30 PM ISTGermany: Researchers have found in a new study that intimate physical contact lowers cortisol levels and, together with oxytocin, enhances wound...
Study Finds Mixed Melanoma Risk Patterns Linked to Tattoos Dr. Shravani Dali27 Nov 2025 8:30 PM ISTAccording to a new study published in the Journal of the National Cancer Institute by Rachel D. McCarty, Britton Trabert, Lindsay J. Collin, Morgan M....
Enhanced Post-discharge Care may improve outcomes among SJS/TEN Patients: JAMA Jacinthlyn Sylvia26 Nov 2025 8:30 PM ISTA new study published in the Journal of the American Medical Association highlighted coordinated post-discharge care between patients and primary...
Sanofi-Regeneron Dupixent approved in EU for chronic spontaneous urticaria Ruchika Sharma26 Nov 2025 1:00 PM ISTParis: Sanofi has announced that the European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic...
Baricitinib + TCS Outperforms Azathioprine in Moderate-to-Severe Atopic Dermatitis: Study Medha Baranwal25 Nov 2025 9:00 PM ISTIran: Researchers have found in a new study that baricitinib combined with topical corticosteroids showed greater effectiveness than azathioprine plus...
Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study Dr. Garima Soni25 Nov 2025 11:45 AM ISTIn the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT study, provides an...
Study finds link between eczema patterns and children's ability to outgrow food allergies Dr. Kamal Kant Kohli25 Nov 2025 7:30 AM ISTNew research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that the timing of when...
Secukinumab Offers Better Psychological Benefits in Psoriasis Treatment: Study Medha Baranwal23 Nov 2025 9:00 PM ISTChina: Researchers have found in a new study that secukinumab and ixekizumab demonstrate comparable clinical efficacy for moderate-to-severe...
